Investigational Oral Contraceptive Has Selective Impact on Endocrine Markers On 2021-03-16 NEW YORK (Reuters Health) – A new, next-generation combined oral contraceptive (COC) containing estetrol (E4) 15 mg and drospirenone (DRSP) […]